These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Editorial: anti-tumour necrosis factor α antibodies - can efficacy be regained? Bar-Yoseph H; Chowers Y Aliment Pharmacol Ther; 2017 Jun; 45(11):1473-1474. PubMed ID: 28474829 [No Abstract] [Full Text] [Related]
4. Letter: switching from one to another anti-tumour necrosis factor alpha agent, and the risks of an overlap of exposure--authors' reply. Gisbert JP; Chaparro M Aliment Pharmacol Ther; 2016 May; 43(9):1020. PubMed ID: 27040169 [No Abstract] [Full Text] [Related]
10. Properties of monoclonal antibodies to human tumor necrosis factor alpha (TNF alpha). McLaughlin PJ; Elwood NJ; Russell SM; Andrew SM; McKenzie IF Anticancer Res; 1992; 12(4):1243-6. PubMed ID: 1503416 [TBL] [Abstract][Full Text] [Related]
11. Editorial: total anti-drug antibodies detected using drug-tolerant assays during induction with anti-TNF therapy are associated with treatment failure-out of sight but not out of mind. Authors' reply. Roblin X; Nancey S; Paul S Aliment Pharmacol Ther; 2021 Jun; 53(12):1319-1320. PubMed ID: 34029416 [No Abstract] [Full Text] [Related]